Gianluca Pettiti Receives Stock Award at Thermo Fisher Scientific Inc (TMO) — SEC Form 4, Feb 24, 2023

SEC Form 4 · No Market Transaction
Stock Award

Compensation grant — no market purchase or sale.

Reporting Owner
TXN 2023-02-23 · FILED 2023-02-24
Equity Position 20.7K sh 15,621 → 20,733
Equity Change +32.7% shares held after vs before
Filing Lag 1 business day within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Filing Date
2023-02-24
Report Date
2023-02-22
Accession No.
0001127602-23-007102
Accepted At
2023-02-24 22:15 UTC
Reporting Owner
Name Relationship
Gianluca Pettiti CIK 0001844600
EVP
Gianluca Pettiti at Thermo Fisher Scientific Inc Full insider history
Bought (12 mo) —
Sold (12 mo) $4,892,277
More from this insider at Thermo Fisher Scientific Inc
2026-09-01 Sell -$2,539,233 View
2026-07-28 Sell -$226,000 View
2026-04-29 Sell -$185,064 View
2026-03-02 - — View
2026-02-27 Award — View
All filings by this insider at Thermo Fisher Scientific Inc
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Common Stock 2023-02-22 A - Award/Grant 1,465 A $0.00 — 15,915 Direct
Common StockF1 2023-02-22 A - Award/Grant 4,818 A $0.00 — 20,733 Direct
Common Stock 2023-02-23 F - Tax Payment 449 D $550.95 -$247,377 20,284 Direct
Common Stock 2023-02-23 F - Tax Payment 722 D $550.95 -$397,786 19,562 Direct
Derivative Securities Transactions
Title Strike Date Type Shares Price Expiration Underlying Ownership
Stock Option (Right to Buy)F2 $548.40 2023-02-22 A - Award/Grant 9,702 A $0.00 2031-02-22 9,702 Common Stock Direct
Footnotes (2)
F1
Shares represent a performance-based restricted stock unit award granted on February 23, 2022. The Company's Compensation Committee determined on February 22, 2023, that the performance criteria related to this award were satisfied. One-third of the shares vest on February 28, 2023 and 2024. The remaining one-third will vest on February 28, 2025, and is subject to adjustment (positive or negative) for long-term performance which is based on the comparison of the Company's total shareholder return compound annual growth rate ("CAGR") to the total shareholder return CAGR of each of the companies in the peer group, as specified within the award agreement, over the measurement period starting on January 1, 2022, through to December 31, 2024. Show more
F2
The option vests in four equal annual installments beginning on February 28, 2024. Show more
5%+ Holders · 13D/G 2 filers
Other insiders at Thermo Fisher Scientific Inc
All Thermo Fisher Scientific Inc insider activity
GET /v1/forms/4/0001127602-23-007102 API docs
View Original SEC Filing